PMR 292932: A Nationally Representative Drug Utilization Study of OxyContin in Children Aged 17 Years and Younger

Clinical Trial Grant

Duke Scholars

Principal Investigator Christoph Paul Vincent Hornik Pediatrics, Critical Care Medicine

Administered By

Duke Clinical Research Institute

Awarded By

Purdue Pharma

Start Date

April 18, 2018

End Date

April 30, 2021

Administered By

Duke Clinical Research Institute

Awarded By

Purdue Pharma

Start Date

April 18, 2018

End Date

April 30, 2021